Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 7/20 | 0.36 |
| ▸ | CTSK | P43235 | 4/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409974 | 1.00 | PLA2G7 (0.50) | PLA2G7MAPTELANEALDH1A1TSHR | |
| SCHEMBL8627827 | 1.00 | PLA2G7 (0.50) | PLA2G7MAPTELANEALDH1A1TSHR | |
| SCHEMBL209658 | 1.00 | PLA2G7 (0.50) | PLA2G7MAPTELANEALDH1A1TSHR | |
| SCHEMBL73083 | 1.00 | PLA2G7 (0.50) | PLA2G7MAPTELANEALDH1A1TSHR | |
| SCHEMBL8547007 | 0.93 | PLA2G7 (0.45) | PLA2G7MAPTELANEALDH1A1TSHR | |
| SCHEMBL7045591 | 0.87 | ELANE (0.41) | PLA2G7MAPTELANEALDH1A1TSHR | |
| SCHEMBL25377184 | 0.86 | PLA2G7 (0.58) | PLA2G7MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL2635874 | 0.86 | PLA2G7 (0.58) | PLA2G7MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL2635878 | 0.86 | PLA2G7 (0.58) | PLA2G7MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL11330082 | 0.86 | ELANE (0.41) | PLA2G7MAPTELANETSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637702-B2 | Process for preparing substituted imidazo[1,5-α]pyrazines | HOFFMANN-LA ROCHE INC. (US) | 2026-05-26 | — | — | US | claimed |
| CN-122059936-A | DASA compound and preparation method and application thereof | 中山大学 | 2026-05-19 | — | — | CN | claimed |
| WO-2025027521-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF AVIBACTAM AND INTERMEDIATE THEREOF | FRESENIUS KABI ONCOLOGY LTD. (IN) | 2025-02-06 | — | — | WO | claimed |
| US-20240391878-A1 | METHOD FOR PREPARING TERT-BUTYL (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-1-CARBOXYLATE AND SALTS THEREOF AND ITS USE IN A METHOD FOR PREPARING (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE AND SALTS THEREOF | MOEHS IBERICA, S.L. (ES) | 2024-11-28 | — | — | US | claimed |
| EP-4467534-A1 | METHOD FOR PREPARING TERT-BUTYL (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-1-CARBOXYLATE AND SALTS THEREOF AND ITS USE IN A METHOD FOR PREPARING (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE AND SALTS THEREOF | Moehs Ibérica, S.L. (ES) | 2024-11-27 | — | — | EP | claimed |
| CN-118020766-A | High-dispersion wettability auxiliary agent and application thereof | 河北成悦化工有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| EP-4286393-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | Daiichi Sankyo Company, Limited (JP) | 2023-12-06 | — | — | EP | claimed |
| CN-116867795-A | Novel method for producing antibody-immunostimulant conjugate | 第一三共株式会社 | 2023-10-10 | — | — | CN | claimed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | claimed |
| US-20040006137-A1 | Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone | BRISTOL-MYERS SQUIBB COMPANY | 2004-01-08 | — | — | US | claimed |
| US-20030139470-A1 | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | HAARMANN & REIMER GMBH (DE) | 2003-07-24 | — | — | US | claimed |
| EP-1218338-A1 | PREPARATION OF AMINO-PROTECTED LYSINE DERIVATIVES | ABBOTT LABORATORIES (US) | 2002-07-03 | — | — | EP | claimed |
| US-20020042536-A1 | PREPARATION OF AMINO-PROTECTED LYSINE DERIVATIVES | ABBOTT LABORATORIES | 2002-04-11 | — | — | US | claimed |
| US-6313292-B1 | REACTION FROM 5-AMINO-2-FLUOROPYRIDINE; AMINATION, CYCLIZATION, CHLORINATION, SALT FORMATION, DECHLORINATION, DEBLOCKING | WARNER-LAMBERT COMPANY | 2001-11-06 | — | — | US | claimed |
| WO-2001027074-A1 | PREPARATION OF AMINO-PROTECTED LYSINE DERIVATIVES | ABBOTT LABORATORIES (US) | 2001-04-19 | — | — | WO | claimed |
| EP-0629189-B1 | PREPARATION OF INTERMEDIATES IN THE SYNTHESIS OF QUINOLINE ANTIBIOTICS | PFIZER (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0133795-B1 | GABA ESTERS AND GABA ANALOGUE ESTERS | THE McLEAN HOSPITAL CORPORATION (US) | 1989-01-18 | — | — | EP | claimed |
| WO-1985000520-A1 | GABA ESTERS AND GABA ANALOGUE ESTERS | THE MCLEAN HOSPITAL CORPORATION (US) | 1985-02-14 | — | — | WO | claimed |
| US-4205183-A | Facile method for isolating resolved amino acids | BECKMAN INSTRUMENTS, INC. (US) | 1980-05-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391878-A1 | METHOD FOR PREPARING TERT-BUTYL (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-1-CARBOXYLATE AND SALTS THEREOF AND ITS USE IN A METHOD FOR PREPARING (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE AND SALTS THEREOF | ADRA1A, AVPR1A, THRA | PLA2G7 4104/4885MAPT 2541/4885ELANE 1146/4885 |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | PAICS, COASY, CDS2 | PLA2G7 927/4885MAPT 4562/4885ELANE 4683/4885 |
| US-20040006137-A1 | Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone | MMP8, MMP9, ADAM8 | PLA2G7 1608/4885MAPT 2460/4885ELANE 131/4885 |
| US-20020042536-A1 | PREPARATION OF AMINO-PROTECTED LYSINE DERIVATIVES | DNPEP, PHYKPL, KARS1 | PLA2G7 2020/4885MAPT 2154/4885ELANE 2179/4885 |
| US-20030139470-A1 | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | TYR, HAAO, TH | PLA2G7 3428/4885MAPT 1335/4885ELANE 3380/4885 |
| US-12637702-B2 | Process for preparing substituted imidazo[1,5-α]pyrazines | BCKDK, P4HB, DOHH | PLA2G7 2148/4885MAPT 4554/4885ELANE 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.